OAB-050: Randomized phase 2 study of weekly carfilzomib 70 mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple (MM) patients (GEMKyCyDex)
- Resource Type
- Abstract
- Authors
- Puertas, Borja; González, Verónica; Sureda, Anna; Moreno, Mª José; Oriol, Albert; González, Mª Esther; Rosiñol, Laura; López, Jordi; Escalante, Fernando; López, Joaquín Martinez; Carrillo, Estrella; Clavero, Esther; Rodríguez, Ana Pilar González; Dourdil, Victoria; de la Fuente, Felipe de Arriba; González, Marta Sonia; de Oteyza, Jaime Pérez; Hernández, Miguel teodoro; Mateo, Aránzazu García; Blade, Joan; Palacios, Juan José Lahuerta; San-Miguel, Jesus; Ocio, Enrique; Mateos, María-Victoria
- Source
- In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S30-S31
- Subject
- Language
- ISSN
- 2152-2650